{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:44:09Z","timestamp":1772163849739,"version":"3.50.1"},"reference-count":32,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1136\/thoraxjnl-2014-206716","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T12:21:24Z","timestamp":1452774084000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis"],"prefix":"10.1136","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6745-7932","authenticated-orcid":false,"given":"Ruth L","family":"Dentice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R","family":"Elkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A B","family":"Wark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J","family":"Dorahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J","family":"Harmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter T P","family":"Bye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"key-10.1136\/thoraxjnl-2014-206716-1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.med.58.071905.105316","article-title":"Airway surface dehydration in CF: pathogenesis and therapy","volume":"58","author":"Boucher","year":"2007","journal-title":"Annu Rev Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"key-10.1136\/thoraxjnl-2014-206716-4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/thx.2011.161117","article-title":"Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis","volume":"66","author":"de Boer","year":"2011","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-206716-5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.00159111","article-title":"Effect of pulmonary exacerbations on long term lung function decline in cystic fibrosis","volume":"40","author":"Waters","year":"2012","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-206716-6","first-page":"711","article-title":"The impact of treatment of pulmonary exacerbations on the health-related quality of life of patients with cystic fibrosis: does hospitalization make a difference?","volume":"144","author":"Yi","year":"2004","journal-title":"J Pediatr"},{"key":"key-10.1136\/thoraxjnl-2014-206716-7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1097-2765(01)00286-6","article-title":"The CF salt controversy: in vivo observations and therapeutic approaches","volume":"8","author":"Tarran","year":"2001","journal-title":"Mol Cell"},{"key":"key-10.1136\/thoraxjnl-2014-206716-8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/thx.52.10.900","article-title":"Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis","volume":"52","author":"Robinson","year":"1997","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-206716-9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M","article-title":"Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis","volume":"21","author":"Eng","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"key-10.1136\/thoraxjnl-2014-206716-10","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/ajrccm.153.5.8630593","article-title":"Effect of hypertonic saline, amiloride and cough on mucociliary clearance in patients with cystic fibrosis","volume":"153","author":"Robinson","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fmicb.2010.00120","article-title":"Hypertonic saline therapy in cystic fibrosis: do population shifts caused by the osmotic sensitivity of infecting bacteria explain the effectiveness of this treatment?","volume":"1","author":"Williams","year":"2010","journal-title":"Frontiers Microbiol"},{"key":"key-10.1136\/thoraxjnl-2014-206716-13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jcf.2007.11.009","article-title":"Inhibitory effects of hypertonic saline on P. aeruginosa motility","volume":"7","author":"Havasi","year":"2008","journal-title":"J Cyst Fibros"},{"key":"key-10.1136\/thoraxjnl-2014-206716-14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1039\/b918710c","article-title":"Metabolic profiling of Pseudomonas aeruginosa demonstrates that the anti-sigma factor MucA modulates osmotic stress tolerance","volume":"6","author":"Behrends","year":"2010","journal-title":"Mol Biosyst"},{"key":"key-10.1136\/thoraxjnl-2014-206716-15","first-page":"CD001506","article-title":"Nebulised hypertonic saline for cystic fibrosis","volume":"3","author":"Wark","year":"2005","journal-title":"Cochrane Datab Syst Rev"},{"issue":"(S1)","key":"key-10.1136\/thoraxjnl-2014-206716-16","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1569-1993(13)60117-4","article-title":"A randomised controlled trial of the effect of hypertonic saline (HS) inhalation on exacerbation resolution, hospital length of stay and time to relapse in adults with cystic fibrosis","volume":"12","author":"Dentice","year":"2013","journal-title":"J Cyst Fibros"},{"key":"key-10.1136\/thoraxjnl-2014-206716-17","first-page":"257","article-title":"A randomised trial of hypertonic saline nebulisation during hospitalisation for pulmonary exacerbations in adults with cystic fibrosis","volume":"S35","author":"Dentice","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"key-10.1136\/thoraxjnl-2014-206716-18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-19","first-page":"CD001506","article-title":"Nebulised hypertonic saline for cystic fibrosis","volume":"2","author":"Wark","year":"2009","journal-title":"Cochrane Datab Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2014-206716-20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2466-11-45","article-title":"Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis","volume":"11","author":"Laube","year":"2011","journal-title":"BMC Pulm Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.200204-293OC","article-title":"Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects","volume":"167","author":"Sood","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with Cystic Fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-23","volume-title":"Physiotherapy for people with cystic fibrosis: from infant to adult","author":"McIlwaine","year":"2009","edition":"4"},{"issue":"(S32)","key":"key-10.1136\/thoraxjnl-2014-206716-24","first-page":"369","article-title":"Reliability and repeatability of the MST-25: an extension of the Modified Shuttle Test (MST)","volume":"44","author":"Elkins","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"key-10.1136\/thoraxjnl-2014-206716-25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey: conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"key-10.1136\/thoraxjnl-2014-206716-26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jpepsy\/25.6.403","article-title":"Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis","volume":"25","author":"Quittner","year":"2000","journal-title":"J Pediatr Psychol"},{"key":"key-10.1136\/thoraxjnl-2014-206716-27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1836-9553(12)70070-X","article-title":"Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial","volume":"58","author":"Dentice","year":"2012","journal-title":"J Physiother"},{"key":"key-10.1136\/thoraxjnl-2014-206716-28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-206716-29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ppul.21117","article-title":"Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis","volume":"45","author":"Sanders","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"key-10.1136\/thoraxjnl-2014-206716-30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ppul.21374","article-title":"Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis","volume":"46","author":"Sanders","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"(S34)","key":"key-10.1136\/thoraxjnl-2014-206716-31","first-page":"331","article-title":"Retrospective evaluation of appropriate duration of intravenous antibiotic therapy for acute cystic fibrosis exacerbations","volume":"36","author":"Leonard","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"key-10.1136\/thoraxjnl-2014-206716-32","doi-asserted-by":"crossref","first-page":"e000407","DOI":"10.1136\/bmjopen-2011-000407","article-title":"Inhaled hypertonic saline in adults hospitalised for exacerbation of cystic fibrosis lung disease: a retrospective study","volume":"2","author":"Pezzulo","year":"2012","journal-title":"BMJ Open"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2014-206716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:50:43Z","timestamp":1601085043000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2014-206716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,1,14]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1136\/thoraxjnl-2014-206716"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206716","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726080765.793545678","asserted-by":"object"}]},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}